Protalix BiotherapeuticsPLX
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 77 institutions reported holding Protalix Biotherapeutics Inc. (PLX) in their 13F filings, up 14 from Q2 2025. 17 opened new positions and 3 sold out. The largest holders were BlackRock, Inc. ($7.9M), Opaleye Management Inc. ($5.7M) and Renaissance Technologies ($2.9M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Protalix Biotherapeutics Inc.
- CUSIP
- 74365A309
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 17 | $6.5M |
| Exits | 3 | $321K |
All 13F filers, Q2 2025 → Q3 2025: 3,605,944 shares bought and 1,587,252 shares sold, net +2,018,692 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 77 holders
| BlackRock, Inc. | 0.00% | Add +5.4% | 3,551,028 | $7.9M |
| Opaleye Management Inc. | 0.82% | New | 2,580,556 | $5.7M |
| Renaissance Technologies | 0.00% | Reduce -18.6% | 1,315,400 | $2.9M |
| Northern Trust Corp. | 0.00% | Reduce -16.4% | 902,459 | $2.0M |
| Geode Capital Management, LLC | 0.00% | Reduce -0.8% | 819,777 | $1.8M |
| Stratos Wealth Partners, LTD. | 0.01% | Add +42.9% | 500,000 | $1.1M |
| State Street Corp. | 0.00% | Add +12.2% | 498,547 | $1.1M |
| Vanguard Group Inc. | 0.00% | Reduce -4.2% | 464,421 | $1.0M |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Reduce -19.3% | 400,398 | $889K |
| UBS Group AG | 0.00% | Add +153.2% | 190,276 | $422K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 189,100 | $420K |
| Diametric Capital, LP | 0.15% | Add +25.6% | 179,984 | $400K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 175,070 | $389K |
| Commonwealth Equity Services, LLC | 0.00% | Reduce -12.7% | 171,772 | $381K |
| Evergreen Capital Management LLC | 0.01% | No change | 171,338 | $380K |
| Goldman Sachs Group Inc. | 0.00% | Add +47.6% | 150,829 | $335K |
| Bank of New York Mellon Corp | 0.00% | Add +3.2% | 138,548 | $308K |
| Main Street Financial Solutions, LLC | 0.02% | New | 129,100 | $287K |
| Barclays PLC | 0.00% | Reduce -19.8% | 101,798 | $226K |
| Nuveen, LLC | 0.00% | No change | 90,188 | $200K |
| XTX Topco Ltd | 0.01% | Add +16.5% | 85,841 | $191K |
| Susquehanna International Group, LLP | 0.00% | Reduce -75.6% | 72,922 | $162K |
| Morgan Stanley | 0.00% | Reduce -84.6% | 71,037 | $158K |
| Wolverine Trading, LLC | 0.00% | Add +187.2% | 70,394 | $152K |
| Deutsche Bank AG | 0.00% | New | 65,617 | $146K |
| Rhumbline Advisers | 0.00% | Reduce -6.6% | 65,194 | $145K |
| Orin Green Financial, LLC | 0.05% | No change | 61,200 | $136K |
| Prelude Capital Management, LLC | 0.01% | Reduce -11.2% | 49,791 | $111K |
| Invesco Ltd. | 0.00% | Reduce -0.3% | 45,003 | $100K |
| Wells Fargo & Company | 0.00% | Add +18.9% | 42,831 | $95K |
| New York State Common Retirement Fund | 0.00% | Reduce -40.1% | 41,300 | $92K |
| State of Wyoming | 0.01% | New | 39,018 | $87K |
| Citadel Advisors | 0.00% | New | 37,306 | $83K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 35,278 | $79K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Reduce -15.3% | 32,253 | $72K |
| Intech Investment Management LLC | 0.00% | Reduce -14.4% | 31,248 | $69K |
| JPMorgan Chase & Co. | 0.00% | Reduce -13.2% | 29,991 | $67K |
| Earned Wealth Advisors, LLC | 0.01% | Reduce 0.0% | 25,975 | $58K |
| Aptus Capital Advisors, LLC | 0.00% | Add +3.5% | 25,727 | $57K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 24,054 | $53K |
| Bank of America Corp. | 0.00% | Reduce -8.1% | 20,119 | $45K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | No change | 18,554 | $41K |
| Cascade Financial Partners, LLC | 0.00% | No change | 17,000 | $38K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -62.6% | 17,028 | $38K |
| Virtu Financial LLC | 0.00% | New | 16,530 | $37K |
| Lido Advisors, LLC | 0.00% | No change | 15,554 | $35K |
| BNP Paribas Financial Markets | 0.00% | Add +126.5% | 15,215 | $34K |
| Altshuler Shaham Ltd | 0.00% | No change | 12,142 | $27K |
| ProShare Advisors LLC | 0.00% | Reduce -16.6% | 11,922 | $26K |
| Alliancebernstein L.P. | 0.00% | No change | 11,720 | $26K |
| Kestra Advisory Services, LLC | 0.00% | New | 11,000 | $24K |
| Two Sigma Advisers, LP | 0.00% | New | 10,300 | $23K |
| LPL Financial LLC | 0.00% | New | 10,291 | $23K |
| Harbour Investment Management LLC | 0.01% | No change | 10,100 | $22K |
| Legal & General Group Plc | 0.00% | No change | 7,757 | $17K |
| Russell Investments Group, Ltd. | 0.00% | New | 7,465 | $17K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 7,119 | $16K |
| Citigroup Inc. | 0.00% | Reduce -73.3% | 6,614 | $15K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 6,000 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +4240.9% | 5,513 | $12K |
| California State Teachers Retirement System | 0.00% | Add +0.1% | 4,353 | $10K |
| Simplex Trading, LLC | 0.00% | New | 2,942 | $6K |
| Truvestments Capital LLC | 0.00% | No change | 2,458 | $5K |
| Amalgamated Bank | 0.00% | No change | 2,381 | $5K |
| Investment Research & Advisory Group, Inc. | 0.00% | No change | 1,000 | $2K |
| Royal Bank of Canada | 0.00% | Add +266.2% | 1,073 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 700 | $1K |
| FMR LLC | 0.00% | New | 438 | $972 |
| Activest Wealth Management | 0.00% | No change | 300 | $666 |
| Arax Advisory Partners | 0.00% | New | 296 | $658 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 250 | $555 |
| Y.D. More Investments Ltd | 0.00% | No change | 220 | $488 |
| SBI Securities Co., Ltd. | 0.00% | Add +0.5% | 201 | $446 |
| Sterling Capital Management LLC | 0.00% | Add +0.6% | 169 | $375 |
| PNC Financial Services Group, Inc. | 0.00% | New | 35 | $78 |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 25 | $56 |
| Cwm, LLC | 0.00% | New | 163 | $0 |
"% of holder's portfolio" is PLX's weight in each manager's 13F, not the share of Protalix Biotherapeutics Inc. the manager owns.